Abstract 1500P
Background
Approximately 50% of deaths worldwide occur in an acute hospital setting. Doctors-in-training (DITs) experience death & dying in many forms and settings, and at every stage of their medical training. They often feel unprepared or unsupported when providing this care, which can cause significant distress. Yet, our experience is that DITs do not receive much, if any, specific training or support in approaching these events. The purpose of this study is to establish the training and education received by DITs in Cork University Hospital in dealing with death and explore the concept of spirituality in relation to their own experiences.
Methods
We performed a qualitative survey of DITs using a 27-question electronic survey. Participants answered questions regarding the prior training or education they had received relating to death and dying, their confidence in recognising and managing dying, and their opinion on the adequacy of the training or support available currently. A modified version of the Spiritual Wellbeing Scale (SWBS) questionnaire, a validated tool to provide an overall measure of perceived spiritual quality of life, was used to assess impact on spirituality.
Results
130 DITs responded to our survey (female=75). 67% disagreed or strongly disagreed (n=87) that they have received adequate training in relation to death & dying. Almost half did not feel confident discussing end-of-life care with patients or their families (n=63), and 69% (n=88) felt that support offered after the death of a patient was inadequate. The vast majority agreed or strongly agreed (n=124) that end-of-life care was important to the delivery of acute care. 71% (n=92) reported that the death of a patient had had a personal impact on them. The median Existential Wellbeing Score was 44 (range 24-59), indicating a moderate sense of life satisfaction. Of note, however, 49% (n=64) responded that they felt unsettled about their future.
Conclusions
Patient deaths frequently impact DITs. This survey highlights the importance of improving the training and supports available to DITs in dealing with death & dying. This has the potential to benefit both DITs, through better wellbeing, and their patients, by improving confidence and competence providing end-of-life care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Cork University Hospital Medical Oncology Department.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1574P - Medical oncology residents mentors (MORM): A target for resiliency interventions
Presenter: David Paez
Session: Poster session 10
1575P - Smoke-free policies in outdoor areas: A potential cancer prevention strategy in Spain
Presenter: Karen Ramírez Cervantes
Session: Poster session 10
1576P - Smoking and lung cancer mortality in Italian men and women: 2003-2019
Presenter: Diego Serraino
Session: Poster session 10
1577P - Indoor radon in patients with lung cancer in Spain: Preliminary data from the MIRROR study
Presenter: Marta Garcia De Herreros
Session: Poster session 10
1578P - Perception of LMIC oncologists on meaningful cancer trial endpoints and value of cancer drugs
Presenter: Soumitra Shankar Datta
Session: Poster session 10
1579P - The Dutch national adolescent and young adult (AYA) cancer care network, a data driven learning healthcare system
Presenter: Winette Van Der Graaf
Session: Poster session 10
1580P - Impact of social determinants of health (SDOH) on disparities in next-generation sequencing (NGS) testing in cancer patients (pts) in the US
Presenter: Chadi Hage Chehade
Session: Poster session 10
1581P - AI enabled intervention increased real-world guideline compliant care: Improving genomic testing and cascade genetics for women with ovarian cancer (OC)
Presenter: Premal Thaker
Session: Poster session 10
1582P - Pregnancy and miscarriage in epithelial ovarian cancer (EOC) patients harboring mutational signature of homologous recombination deficiency (HRD)
Presenter: Lorena Incorvaia
Session: Poster session 10
1583P - Trial-level surrogacy of intermediate endpoints in adjuvant or neoadjuvant use of immune checkpoint blockade
Presenter: Luís Leite
Session: Poster session 10